Monday, November 15, 2021

[ASAP] Engineered Nanovaccine Targeting Clec9a+ Dendritic Cells Remarkably Enhances the Cancer Immunotherapy Effects of STING Agonist

TOC Graphic

Nano Letters
DOI: 10.1021/acs.nanolett.1c03243


from Nano Letters: Latest Articles (ACS Publications) https://ift.tt/3Djxykj
via IFTTT

No comments:

Post a Comment